Concepedia

Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer

Shancheng Ren, Chuanliang Xu, Zilian Cui, Yongwei Yu, Weidong Xu, Fubo Wang, Ji Lu, Min Wei, Xin Lü, Xu Gao,

Journal of Molecular Medicine · 2012 · 52 citations · 30 references

DOI

Concepts

References

30

Cancer Statistics, 2010

Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text

, , +16

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Ian F. Tannock, Ronald de Wit, William R. Berry et al. · New England Journal of Medicine · 2004 · 5.7K citations

, , +12

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Daniel P. Petrylak, Catherine M. Tangen, Maha Hussain et al. · New England Journal of Medicine · 2004 · 3.7K citations · Full text

, , +13

Identification of a Primary Target of Thalidomide Teratogenicity

Takumi Ito, Hideki Ando, Takayuki Suzuki et al. · Science · 2010 · 2.1K citations

, , +13

Formation of the Androgen Receptor Transcription Complex

Yongfeng Shang, Molly Myers, Myles Brown · Molecular Cell · 2002 · 666 citations · Full text

, , +12